Penn Heme Onc Fellows grad dinner. Quaker meeting style to honor and thank this amazing class.Residents at the start of COVID & fellowship so disrupted by COVID. @dhjutsw1 Penn Medicine Duke Cancer Univ of MINN Penn Medicine - Abramson Cancer Center lucky to recruit from this class. Tim Brown, MD MSCE

This week, the Penn Medicine Pavilion is illuminated in red to spotlight #WorldSickleCellDay2023 Penn Medicine Kevin B. Mahoney

Diagnosis or recurrent VTE in patients on anticoagulation (AC) is challenging. The efficacy of clinical decisions rules is unclear. D-dimer may be lower on AC. Dr. Vicky Mai reported that patients with low/mod and negative D-Dimer had non-negligible risk of recurrent VTE

Dr. Kylee Martens presented our work at #ISTH2023. We found a stable incidence of VTE over 16 years among a cohort of 434,203 cancer patient in the U.S. Marc Carrier pishko mustafa jamanetwork.com/journals/jaman…

Excellent presentation by @HilaryWhitworth on 🩸🩸 definitions for pediatric VTE work. Love inclusion of “patient important bleeding”! #ISTH2023

📣 Anticoag providers: Discussing HMB should be Standard of Care when treating pts that menstruate🩸 💡 Know the facts ✅ CHCs can be safely cont’d on AC ✅ Quality of life matters 🫶🏼 ✅ TXA may have a role ✅ Apix & Dabi appear to have ⬇️ risk of HMB Bethany Samuelson Bannow MD, MCR #ISTH2023

Confirmation that bone marrow analysis is not usually required in patients with cytopenias and advanced liver disease. Only 1/118 patients was found to have myelodysplasia to explain the cytopenia. tinyurl.com/3xm7rrzc

Platelet counts often fall during pregnancy; decreases below 50X10^3 per cubic millimeter may be due to an autoimmune cause. Detection and management of immune thrombocytopenia may be lifesaving. Read more in “Management of Primary Immune Thrombocytopenia in Pregnancy”:

U.S. Unveils First 10 Drugs for Medicare Price Negotiations medpagetoday.com/washington-wat… As suspected both Eliquis and Xarelto made the list

Congratulations to Douglas Cines, MD (Penn Path & Lab Medicine) on being awarded the 2024 Henry M. Stratton Medal for basic science from ASH for more than 40 years of research discoveries in thrombocytopenic disorders! #PennProud George J. Netto MD spr.ly/6017iTHu5

Patients with hereditary hemorrhagic telangiectasia (HHT) received pomalidomide or placebo for 24 weeks. Pomalidomide reduced epistaxis frequency and severity. Full PATH-HHT trial results: nej.md/3MUk9VW

How come nobody ever told me about Pittsburgh? It’s so nice here with the hills and the water and lots of sauerkraut for some reason. Big fan.

Such awesome work Kelly Beck, Ph.D. !! YourMomCares Organization Awards $100,000 to Project Aiding Neurodivergent Children in Schools people.com/your-mom-cares… via People

Our review out today on immune TTP

Each day, SEPTA buses and other public transit help health care staff get to their jobs and patients reach care. Proposed service cuts and fare hikes put these essential trips at risk. Act now to protect affordable, reliable transit: spr.ly/60084b3cs.

When compared with the standard assays to assess #ADAMTS13 activity for suspected TTP, newer point-of-care rapid assays demonstrated higher diagnostic accuracy and concordance and lower rates of discrepancies: ow.ly/Eqwz50WktlM #thrombosis #ClottingDisorders #classicalheme

Three videos show echocardiography in a woman who presented with acute pain, swelling, and bruising on the upper portion of her left knee after using an electronic massage gun. Read the full case details in the Clinical Problem-Solving article “A Fruitful Workup” by N. Jain et

This guy is ready for #ASH25

Dr Wang from MSK and previous fellow at Penn presenting a very interesting analysis of differences in outcomes of Asian patients with AML #ASHKudos #ASH25 Xin Wang

Love this graphic from great BDUC talk for working up abnormal bleeding! 🩸 #ASH25